Photoimmunotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Therapeutic Area (Head & Neck Cancer, Metastatic Melanoma, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Biotechnology & Pharmaceutical Companies, Others), and By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

The global photoimmunotherapy market is anticipated to witness robust CAGR  in the forecast period, 2023-2027. Factors such as the increasing prevalence of cancer worldwide, growing healthcare expenditure of consumers, and ongoing research and development activities to find novel cancer treatment therapies primarily drive the demand for the global photoimmunotherapy market. The rise in the investments by the leading authorities to develop the healthcare infrastructure and hire skilled healthcare professionals and favorable government reimbursement policies are the other prominent factors that can accelerate the global photoimmunotherapy market growth over the next five years.

Increased Cancer Prevalence Worldwide Drives the Market Growth

Cancer is a major health concern and is a leading cause of death across the globe. It is a generic term for a large group of diseases that can affect any part of the body. According to World Health Organization, cancer accounted for nearly 10 million deaths in 2020. During cancer, there is the rapid creation of abnormal cells that grow beyond their usual boundaries and can invade the adjoining parts of the body and spread to other organs, and the process is called metastasis. Some of the most common kinds of cancer are breast, lung, colon, rectum, and prostate cancers. In 2020, due to lung cancer, around 1.0 million deaths were observed. Similarly, for colon and rectum and liver cancer, the number of deaths in 2020 was 916000 and 830000. Adoption of an unhealthy and sedentary lifestyle by consumers, high body mass index, high alcohol, and tobacco consumption, and low fruit and vegetable intake is the main cancer-causing factors. The other cancer-causing infections, such as hepatitis and human papillomavirus (HPV), are responsible for cancer in low and lower-middle-class income families. Approximately 400 000 children develop cancer every year, and cervical cancer is the most common cancer in 23 countries. Cancer can be reduced through early detection of cancer and the right treatment and care of the patients suffering from cancer. The majority of cancers can be cured if detected and treated early. Photoimmunotherapy is the recently developed hybrid cancer therapy that directly kills cancer as well as produces a therapeutic host immune response. Conventional immunotherapies such as checkpoint inhibition, engineered T cells and suppressor cell depletion, and immune-activating cytokine therapy do not directly destroy the cancer cells and rely on activating the immune system. Photoimmunotherapy selectively destroys the cancer cells, which releases cancer antigens from dying cancer cells. Therefore, the increased cancer incidence worldwide and the high mortality rate due to cancer are expected to bolster the global photoimmunotherapy market growth over the forecast period.

Favorable Government Policies Supports the Market Growth

The government is concerned with the growing number of cancer cases and is taking steps to lower the patient mortality rate due to cancer. They are providing financial support, reimbursing the cost incurred during the cancer treatment procedures, and funding cancer treatment research and development activities, among others. In India, some of the steps taken by the government that can fund cancer treatment are Health Minister’s Cancer Patient Fund, The Health Minister’s Discretionary Grants, The Central Government Health Scheme (CGHS), National Health Protection Scheme and The Prime Minister’s National Relief Fund. Leading authorities are also promoting the adoption of novel technologies to treat cancer effectively. Massive support from the government is making the market players invest and find new solutions for cancer treatment. Therefore, supportive government policies and the entry of new market players are expected to play a major role in boosting the global photoimmunotherapy market growth over the next five years.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The global photoimmunotherapy market is segmented into therapeutic area, end user, regional distribution, and competitive landscape. Based on therapeutic area, the market is divided into head & neck cancer, metastatic melanoma, and others. Based on end user, the market is divided into hospitals & clinics, ambulatory care centers, biotechnology & pharmaceutical companies, and others. The market analysis also studies the regional segmentation, which is divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region. In terms of country, the United States is expected to hold a significant market share due to the early adoption of advanced technologies by the healthcare sector and the presence of major market players in the country.

Market Players

Rakuten Medical, Inc., Shimadzu Corporation, Modulight Corporation, Steba Biotech Ltd., Luzitin SA are the major market players operating in the global photoimmunotherapy market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Therapeutic Area

·         End User

Regional scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Columbia; South Africa; UAE; Saudi Arabia

Key companies profiled

Rakuten Medical, Inc., Shimadzu Corporation, Modulight Corporation, Steba Biotech Ltd., Luzitin SA

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global photoimmunotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Photoimmunotherapy Market, By Therapeutic Area:
    • Head & Neck Cancer
    • Metastatic Melanoma
    • Others
  • Photoimmunotherapy Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Care Centers
    • Biotechnology & Pharmaceutical Companies
    • Others
  • Photoimmunotherapy Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  UAE

§  Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global photoimmunotherapy market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global photoimmunotherapy market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Photoimmunotherapy Market

5.    Voice of Customer

5.1.  Therapy Awareness

5.2.  Cancer Prevalence, By Gender

5.3.  Cancer Prevalence, By Age Group

5.4.  Cancer Prevalence, By Region

6.    Clinical Trial Analysis

7.    Patent Analysis

8.    Global Photoimmunotherapy Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Therapeutic Area (Head & Neck Cancer, Metastatic Melanoma, Others)

8.2.2.     By End User (Hospitals & Clinics, Ambulatory Care Centers, Biotechnology & Pharmaceutical Companies, Others)

8.2.3.     By Company (2021)

8.2.4.     By Region

8.3.  Product Market Map

9.    North America Photoimmunotherapy Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Therapeutic Area

9.2.2.     By End User

9.2.3.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Photoimmunotherapy Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Therapeutic Area

9.3.1.2.2.             By End User

9.3.2.     Mexico Photoimmunotherapy Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Therapeutic Area

9.3.2.2.2.             By End User

9.3.3.     Canada Photoimmunotherapy Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Therapeutic Area

9.3.3.2.2.             By End User

10.  Europe Photoimmunotherapy Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Therapeutic Area

10.2.2.  By End User

10.2.3.  By Country

10.3.              Europe: Country Analysis

10.3.1.  France Photoimmunotherapy Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Therapeutic Area

10.3.1.2.2.           By End User

10.3.2.  Germany Photoimmunotherapy Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Therapeutic Area

10.3.2.2.2.           By End User

10.3.3.  United Kingdom Photoimmunotherapy Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Therapeutic Area

10.3.3.2.2.           By End User

10.3.4.  Italy Photoimmunotherapy Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Therapeutic Area

10.3.4.2.2.           By End User

10.3.5.  Spain Photoimmunotherapy Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           By Therapeutic Area

10.3.5.2.2.           By End User

11.  Asia-Pacific Photoimmunotherapy Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Therapeutic Area

11.2.2.  By End User

11.2.3.  By Country

11.3.              Asia-Pacific: Country Analysis

11.3.1.  China Photoimmunotherapy Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Therapeutic Area

11.3.1.2.2.           By End User

11.3.2.  India Photoimmunotherapy Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Therapeutic Area

11.3.2.2.2.           By End User

11.3.3.  South Korea Photoimmunotherapy Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Therapeutic Area

11.3.3.2.2.           By End User

11.3.4.  Japan Photoimmunotherapy Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Therapeutic Area

11.3.4.2.2.           By End User

11.3.5.  Australia Photoimmunotherapy Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Therapeutic Area

11.3.5.2.2.           By End User

12.  South America Photoimmunotherapy Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Therapeutic Area

12.2.2.  By End User

12.2.3.  By Country

12.3.              South America: Country Analysis

12.3.1.  Brazil Photoimmunotherapy Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Therapeutic Area

12.3.1.2.2.           By End User

12.3.2.  Argentina Photoimmunotherapy Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Therapeutic Area

12.3.2.2.2.           By End User

12.3.3.  Colombia Photoimmunotherapy Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Therapeutic Area

12.3.3.2.2.           By End User

13.  Middle East and Africa Photoimmunotherapy Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Therapeutic Area

13.2.2.  By End User

13.2.3.  By Country

13.3.              MEA: Country Analysis

13.3.1.  South Africa Photoimmunotherapy Market Outlook

13.3.1.1.      Market Size & Forecast

13.3.1.1.1.           By Value

13.3.1.2.      Market Share & Forecast

13.3.1.2.1.           By Therapeutic Area

13.3.1.2.2.           By End User

13.3.2.  Saudi Arabia Photoimmunotherapy Market Outlook

13.3.2.1.      Market Size & Forecast

13.3.2.1.1.           By Value

13.3.2.2.      Market Share & Forecast

13.3.2.2.1.           By Therapeutic Area

13.3.2.2.2.           By End User

13.3.3.  UAE Photoimmunotherapy Market Outlook

13.3.3.1.      Market Size & Forecast

13.3.3.1.1.           By Value

13.3.3.2.      Market Share & Forecast

13.3.3.2.1.           By Therapeutic Area

13.3.3.2.2.           By End User

14.  Market Dynamics

14.1.              Drivers

14.2.              Challenges

15.  Market Trends & Developments

16.  Competitive Landscape

16.1.              Rakuten Medical, Inc.

16.2.              Shimadzu Corporation

16.3.              Modulight Corporation

16.4.              Steba Biotech Ltd.

16.5.              Luzitin SA

17.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The increasing prevalence of cancer worldwide, growing healthcare expenditure of consumers, and ongoing research and development activities to find novel cancer treatment therapies are driving the demand for the global photoimmunotherapy market.

down-arrow

Rakuten Medical, Inc., Shimadzu Corporation, Modulight Corporation, Steba Biotech Ltd., and Luzitin SA are the key players operating in the global photoimmunotherapy market.

down-arrow

Based on end user, the market is divided into hospitals & clinics, ambulatory care centers, biotechnology & pharmaceutical companies, and others. Hospitals & clinics are expected to hold a major market share over the forecast period.

down-arrow

The inability to get near-infrared light to all body parts as it is not able to penetrate tissue deeply may restrain the market growth over the next five years.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Photoimmunotherapy Market to be dominated by North American region through 2027

Aug, 2022

Growing cases of target diseases and the flourishing medical tourism industry are driving the demand for the global photoimmunotherapy market in the forecast period, 2023-2027.

Why Choose Us